ZEC: Don't Buy Until You See This Setup
1 extracted signal · 0 resolved · 1 still active
FJ TradingIndependent analyst profile- Source published
- 23 Aug 2026, 16:22 UTC
- Recorded by Tahlil Plus
- 23 Aug 2026, 18:11 UTC
AI-generated source summary
The video discusses Zcash (ZEC) on a daily chart, noting a significant 90% pump in 13 days, reaching a new all-time high. The analyst identifies key resistance zones between $750-$791 and $900-$1000. A bullish scenario is presented if ZEC breaks and holds above $750, targeting $900-$1000, with potential for further upside to $1,035-$1,053. A short-term retracement is anticipated from the $750-$791 resistance zone, with a potential entry on a pullback and support confirmation. The analyst also points out that ZEC is overbought, suggesting a short-term correction is likely. A hypothetical trading setup is outlined with an entry at $853.27, a target at $990, and a stop-loss at $750, yielding a 1.29 risk-reward ratio. The analyst also mentions that if ZEC breaks below $750 with confirmation, the trend invalidation would occur. The long-term outlook suggests potential further upside to $1,000-$1,035, but the immediate focus is on the potential retracement from the current resistance levels.
AI-generated summary based on the source content.
Signal outcomes at a glance
Tracking LiveSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Source processing completed
Source analysis and structured extraction completed.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
- Live evaluation in progress
1 signal remains active.
FJ Trading
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.